The field of high dose rate (HDR) brachytherapy has witnessed rapid advances in optimisation techniques that aim to balance the dual imperatives of maximising tumour dose while minimising exposure to ...
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...
A Technical Meeting on Patient Dose Monitoring and the Use of Diagnostic Reference Levels for the Optimization of Protection in Medical Imaging was held at the IAEA headquarters on 30 May - 3 June ...
In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
Plus Therapeutics, Inc. has begun treating patients in its ReSPECT-LM dose optimization trial for REYOBIQ (rhenium Re186 obisbemeda), targeting leptomeningeal metastases (LM), a severe complication of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback